目的比较紫杉醇加卡铂与紫杉醇加顺铂治疗晚期乳腺癌的疗效和不良反应。

Objective to evaluate and compare the efficacy and toxicity of paclitaxel plus carboplatin and paclitaxel plus cisplatin for the treatment of advanced breast cancer.

youdao

连续的化学治疗临床试验显示顺铂(或卡铂)加紫杉醇是已经证实最有效的联合。

Sequential clinical trials of chemotherapy agents demonstrate that cisplatin (or carboplatin) given in combination with paclitaxel is the most active combination identified.

youdao

连续的化学治疗临床试验显示顺铂(或卡铂)加紫杉醇是已经证实最有效的联合。

Sequential clinical trials of chemotherapy agents demonstrate that cisplatin (or carboplatin) given in combination with paclitaxel is the most active combination identified.

youdao